Study protocol: Phase I/II trial of induced HLA-G(+) regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor

Regulatory T-cell (Treg) immunotherapy has emerged as a promising and highly effective strategy to combat graft-versus-host disease (GvHD) after allogeneic hematopoietic cell transplantation (allo-HCT). Both naturally occurring Treg and induced Treg populations have been successfully evaluated in tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lysandrou, Memnon, Kefala, Dionysia, Christofi, Panayiota, Savvopoulos, Nikolaos, Papayanni, Penelope Georgia, Theodorellou, Rodanthy, Sagiadinou, Eleftheria, Zacharioudaki, Vassiliki, Moukouli, Maria, Tsokanas, Dimitrios, Karavalakis, Georgios, Liga, Maria, Stavrinos, Konstantinos, Papadopoulou, Anastasia, Yannaki, Evangelia, Spyridonidis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237041/
https://www.ncbi.nlm.nih.gov/pubmed/37275377
http://dx.doi.org/10.3389/fmed.2023.1166871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237041/
https://www.ncbi.nlm.nih.gov/pubmed/37275377
http://dx.doi.org/10.3389/fmed.2023.1166871

Ejemplares similares